147 related articles for article (PubMed ID: 36951158)
1. Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients.
Capecchi M; De Leo P; Abbattista M; Mancini I; Agosti P; Biganzoli M; Suffritti C; Ferrari B; Lecchi A; La Marca S; Padovan L; Scalambrino E; Clerici M; Tripodi A; Artoni A; Gualtierotti R; Peyvandi F
Haematologica; 2023 Nov; 108(11):3152-3155. PubMed ID: 36951158
[No Abstract] [Full Text] [Related]
2. SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura.
Shah H; Kim A; Sukumar S; Mazepa M; Kohli R; Braunstein EM; Brodsky RA; Cataland S; Chaturvedi S
Blood; 2022 Apr; 139(16):2570-2573. PubMed ID: 35259252
[No Abstract] [Full Text] [Related]
3. Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.
Maayan H; Kirgner I; Gutwein O; Herzog-Tzarfati K; Rahimi-Levene N; Koren-Michowitz M; Blickstein D
J Thromb Haemost; 2021 Sep; 19(9):2314-2317. PubMed ID: 34105247
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic Profile and Serological Response of Patients with Immune Thrombotic Thrombocytopenic Purpura after Receiving BNT162b2 Vaccine: A Prospective Study.
Schieppati F; Russo L; Gamba S; Galimberti E; Giaccherini C; Tartari CJ; Bolognini S; Verzeroli C; Ticozzi C; Barcella L; Marchetti M; Falanga A
Thromb Haemost; 2023 Oct; 123(10):945-954. PubMed ID: 37172940
[TBL] [Abstract][Full Text] [Related]
5. Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.
Fang F; Tse B; Pavenski K
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35902184
[TBL] [Abstract][Full Text] [Related]
6. First report of COVID-19 vaccine induced flare of compensated congenital thrombotic thrombocytopenic purpura.
Dykes KC; Kessler CM
Blood Coagul Fibrinolysis; 2022 Jan; 33(1):71-73. PubMed ID: 34693915
[No Abstract] [Full Text] [Related]
7. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.
Waqar SHB; Khan AA; Memon S
Int J Hematol; 2021 Nov; 114(5):626-629. PubMed ID: 34264514
[TBL] [Abstract][Full Text] [Related]
8. Covid-19 vaccination in patients with immune-mediated thrombotic thrombocytopenic purpura: a single-referral center experience.
Trisolini SM; Capria S; Artoni A; Mancini I; Biglietto M; Gentile G; Peyvandi F; Testi AM
Haematologica; 2023 Jul; 108(7):1957-1959. PubMed ID: 36579445
[No Abstract] [Full Text] [Related]
9. Immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
Candelli M; Rossi E; Valletta F; De Stefano V; Franceschi F
Br J Haematol; 2021 Aug; 194(3):547-549. PubMed ID: 33934330
[No Abstract] [Full Text] [Related]
10. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
Saluja P; Gautam N; Yadala S; Venkata AN
Thromb Res; 2022 Jun; 214():115-121. PubMed ID: 35533526
[TBL] [Abstract][Full Text] [Related]
11. Predictors of relapse and prophylactic management of immune thrombotic thrombocytopenic purpura.
Oliver M; Patriquin CJ; Pavenski K
Transfus Apher Sci; 2023 Aug; 62(4):103749. PubMed ID: 37344323
[No Abstract] [Full Text] [Related]
12. An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review.
Kornowski Cohen M; Sheena L; Shafir Y; Yahalom V; Gafter-Gvili A; Spectre G
Acta Haematol; 2021; 144(6):678-682. PubMed ID: 33895748
[TBL] [Abstract][Full Text] [Related]
13. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic Thrombocytopenic Purpura and the Moderna Covid-19 Vaccine.
Julian JA; Mathern DR; Fernando D
Ann Emerg Med; 2021 Jun; 77(6):654-656. PubMed ID: 34030782
[No Abstract] [Full Text] [Related]
15. Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine.
Giuffrida G; Condorelli A; Di Giorgio MA; Markovic U; Sciortino R; Nicolosi D; Di Raimondo F
Haematologica; 2022 Apr; 107(4):1008-1010. PubMed ID: 34382388
[No Abstract] [Full Text] [Related]
16. Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?
Pasin F; Calabrese A; Pelagatti L
Intern Emerg Med; 2022 Jan; 17(1):295-297. PubMed ID: 34100214
[No Abstract] [Full Text] [Related]
17. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
Mariotte E; Azoulay E; Galicier L; Rondeau E; Zouiti F; Boisseau P; Poullin P; de Maistre E; Provôt F; Delmas Y; Perez P; Benhamou Y; Stepanian A; Coppo P; Veyradier A;
Lancet Haematol; 2016 May; 3(5):e237-45. PubMed ID: 27132698
[TBL] [Abstract][Full Text] [Related]
18. Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study.
Giuffrida G; Markovic U; Condorelli A; Calagna M; Grasso S; Duminuco A; Riccobene C; Pelle AC; Zanghi G; Di Raimondo F
Haematologica; 2022 Nov; 107(11):2661-2666. PubMed ID: 35511612
[TBL] [Abstract][Full Text] [Related]
19. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
[TBL] [Abstract][Full Text] [Related]
20. Refractory immune TTP following Pfizer-BioNTech COVID-19 vaccine successfully salvaged with caplacizumab.
Laverdure E; Sperlich C; Fox S
J Thromb Haemost; 2022 Jul; 20(7):1696-1698. PubMed ID: 35510743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
